Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer - Yang, Cai-Zhi; Hu, Lei-Hao; Huang, Zhong-Yu; Deng, Li; Guo, Wei; Liu, Shan; Xiao, Xi; Yang, Hong-Xing; Lin, Jie-Tao; Sun, Ling-Ling; Lin, Li-Zhu (PloS one, 2021)
Keywords: Aged; Algorithms; Analysis; Antineoplastic Agents - therapeutic use; Apoptosis; Area Under Curve; Biological markers; Biology and life sciences; Biomarkers; Biomarkers, Tumor - genetics; Carcinoma, Non-Small-Cell Lung - drug therapy; Carcinoma, Non-Small-Cell Lung - genetics; Carcinoma, Non-Small-Cell Lung - mortality; Carcinoma, Non-Small-Cell Lung - pathology; Cell cycle; Chemotherapy; Cisplatin; Computer and Information Sciences; Dendritic cells; Disease; Drug resistance; Drug Resistance, Neoplasm - genetics; Epidermal growth factor; Female; Gefitinib; Gemcitabine; Gene expression; Gene Regulatory Networks - genetics; Genetic aspects; Genomes; Genotypes; Health risks; Hospitals; Humans; Immunosuppressive agents; Immunotherapy; Inhibitor drugs; Kinases; Lung cancer; Lung cancer, Non-small cell; Lung diseases; Lung Neoplasms - drug therapy; Lung Neoplasms - genetics; Lung Neoplasms - mortality; Lung Neoplasms - pathology; Lymphocytes; Male; Malignancy; Medical prognosis; Medicine; Medicine and Health Sciences; Microenvironments; MicroRNAs; MicroRNAs - metabolism; Middle Aged; miRNA; Modules; mRNA; Network analysis; Non-coding RNA; Non-small cell lung carcinoma; Oncology; Ontology; Paclitaxel; Patient outcomes; Physical Sciences; Prognosis; Proportional Hazards Models; Regression analysis; Research and Analysis Methods; Ribonucleic acid; Risk groups; RNA; RNA - metabolism; RNA, Long Noncoding - metabolism; RNA, Messenger - metabolism; ROC Curve; Small cell lung carcinoma; Survival; Survival Rate; Targeted cancer therapy; Tumorigenesis; China